Tag: Medicine
-
Investigating Quality of Life in Large B-cell Lymphoma
Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.
-
Study Uncovers Potential Therapeutic Approach for Advanced Prostate Cancer
A Northwestern Medicine study has discovered that elevated PALI1 in advanced prostate tumors mediates crosstalk between two primary epigenetic silencing mechanisms, suggesting that dual epigenetic inhibition may be an effective therapeutic strategy.
-
Personalized T-cell Therapy Improves Immune Response Against Cancer
Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.
-
New Center for Collaborative AI in Healthcare
The Institute for Artificial Intelligence in Medicine (I.AIM) has established the Center for Collaborative AI in Healthcare, with the mission of advancing artificial intelligence science, engineering and translation throughout healthcare specialties and create a positive impact on precision medicine.
-
Celebrating 50 Years of the Department of Preventive Medicine
Originally founded in 1972 as a small team of fewer than 10 people, the department has grown to include seven divisions with 285 faculty and staff.
-
Evaluating Treatment Options for Peripheral Artery Disease
Telmisartan, an angiotensin receptor blocker drug, did not improve walking performance in patients with lower extremity peripheral artery disease, according to a recent clinical trial published in JAMA.
-
Investigating the Role of Fatty Acids in Cancer Cell Survival
Northwestern Medicine investigators have discovered that a particular enzyme is essential for regulating cancer cell survival and metastasis under cellular stress, according to a recent study.
-
First Drug to Reduce Risk of Mortality and Hospitalization in Heart Failure
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
-
Investigating Heart Disease Mortality in Asian American Populations
Mortality rates for ischemic heart disease in Asian American subpopulations were found to be more burdensome than previously reported, according to a Northwestern Medicine study published in JAMA Internal Medicine.
-
Inhibiting a Metabolic Regulator in Specialized Immune Cells Increases Inflammation
Therapeutically inhibiting a metabolic regulator in monocytes unexpectedly increased inflammatory signaling, revealing mechanisms that could inform new strategies to treat chronic inflammatory disorders, according to a recent study.
